Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel disease
Ines Schneider, Clarissa Allner, Laura Mühl, Michaela Melde, Donata Lissner, Eleni Mantzivi, Rainer Glauben, Francesco Vitali, Emily Becker, Imke Atreya, Tanja M. Müller, Raja Atreya, Britta Siegmund, Markus F. Neurath, Sebastian Zundler
Topics & Concepts
VedolizumabMedicineInflammatory bowel diseaseInternal medicineClinical trialLeukocyte adhesion deficiencyCohortIntegrinImmunologyDiseaseOncologyCD18ReceptorInflammatory Bowel DiseaseImmunodeficiency and Autoimmune DisordersCell Adhesion Molecules Research